[1]
“A new RP- HPLC Method Development and Validation for the Concurrent Identification of Nivolumab and Hyaluronidase in Bulk and Pharmaceutical Dosage Form”, AJCPR, vol. 13, no. 1, pp. 47–52, Jun. 2025, doi: 10.30904/j.ajcpr.2025.4812.